MSB 7.63% $1.34 mesoblast limited

2023 The Final Countdown, page-1279

  1. 7,860 Posts.
    lightbulb Created with Sketch. 1350
    It's historically where stem cell companies fail, the phase 3. Which is something the FDA will understand when making their decision.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.